Emkay Global Reports Zero Deviation in Preferential Issue Utilization for Q2FY27
Emkay Global Financial Services Ltd · Others (Uncategorized) · 29 Oct 2026, 12:31 am
Emkay Global Reports Zero Deviation in Preferential Issue Utilization for Q2FY27 CARE Ratings confirmed zero deviation in Emkay Global Financial Services' fund utilization for the quarter ended 30th Sep'26, under its ₹227.52 crore convertible warrants preferential issue. Cumulative proceeds received reached ₹92.80 crore, including ₹8.08 crore received and fully utilized during Q2FY27 for working capital needs via fixed deposits backing bank guarantees (₹6.29 crore) and exchange margins (₹1.79 crore). Cumulative working capital utilization stood at ₹92.80 crore, leaving ₹109.71 crore uncalled and ₹25.00 crore unutilized for general corporate purposes.
Original exchange filing (PDF)
More announcements from Emkay Global Financial Services Ltd
- Emkay Global Financial Services Limited has informed the Exchange about intimation of receipt of listing approvals for 3,00,000 Equity shares of Rs. 10 each, allotted pursuant to conversion .... · 13 Nov 2026
- Intimation of receipt of trading approval letters for listing of equity shares from stock exchanges · 04 Nov 2026
- General update on Restructuring · 04 Nov 2026
- Emkay Global Financial Services Limited has informed the Exchange that the Board has approved to enter into a Business Transfer Agreement (BTA) with Emkay Wealth Advisory Limited, for the .... · 29 Oct 2026
- Emkay Global Financial Services Limited has informed the Exchange that: 1. The Board has approved .... · 29 Oct 2026
- Emkay Global Financial Services Limited has informed the Exchange that the Board has approved an investment in the Equity Shares of Emkay Capital Private Limited (ECPL), a wholly owned .... · 29 Oct 2026
- Investor Presentation for quarter ended September 30, 2026 · 29 Oct 2026
- Statement of Material Deviation in case of preferential issue · 28 Oct 2026
